Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD

Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD

Introduction: Non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease (N-ERD) accompanies severe asthma in about 15% of the patients and may adversely affect the prognosis. Omalizumab and mepolizumab are biologics used in patients with severe asthma. The objective of this study...

Full description

Bibliographic Details
Main Authors: Fatma Merve Tepetam, MD, Şeyma Özden, MD, Fatma Kübra Kılıç, MD, Cihan Örçen, MD, Tuğçe Yakut, MD
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:World Allergy Organization Journal
Subjects:
Anti-inflammatory agents
Non-steroidal (NSAID)
Asthma
Aspirin-induced
Omalizumab
Visual analog scale (VAS)
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455123000777

Internet

http://www.sciencedirect.com/science/article/pii/S1939455123000777

Similar Items